A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19
Clinical trial NCT04487574 · COMPLETED
Trial details
- NCT number
- NCT04487574
- Sponsor
- RSV Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-25
- Primary completion
- 2020-10-29
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.